universally available as it has been shown to reduce psychological morbidity in high risk groups. 4 Most departments did not know how a relative finds out the result of a necropsy, although this will usually be available from the coroner's officer. It is important that all relatives should have confirmation of the cause of death. Few do, and it is the responsibility of the accident and emergency staff to ensure that this information is communicated to the family either directly or through their general practitioner. In a time of stress relatives may not be able to absorb much oral inlformation. All bereaved relatives should be given written information as well as oral instructions. There are many advice sheets available from national organisations, as well as leaflets produced by individual hospitals. The leaflets sent out by accident and emergency departments were often incomplete (table II) . IMPROVING CARE Staff in accident and emergency departments appreciate the severe psychological trauma caused by a cot death. Paediatricians, health visitors, and counsellors are often brought in at an early stage. The body is treated as a loved one rather than an inanimate object, as sometimes occurs with adults, and a photograph is often taken as a final lasting memory. Most departments give parents one of the nationally produced leaflets to help them cope with their bereavement. Should not this level ofcare be extended to the relatives of all patients dying in accident and emergency departments? The death of an adult is just as traumatic as the death of a child; the sense of loss is just as great.
Most departments commented on the inadequacy felt by staff when dealing with death, grief, and bereavement. Extra training was widely requested; nurses have in house training at many centres, but it is rare for doctors. One third of deaths in hospital occurred within a few hours of arrival in hospital. 
Introduction
Cytological criteria for diagnosing mild, moderate, or severe dyskaryosis in ceryical smears are well established.' In some cases, however, smears show only minor nuclear abnormalities that could reflect either the effects of inflammation or the potential for neoplastic growth, and these two possibilities cannot be distinguished cytologically. The British Society for Clinical Cytologists recommended that the term borderline be used to describe such smears.
I
Data from the Avon Cervical Screening Programme have shown a steady annual increase in the number of women whose cervical smears are designated as borderline. In 1981, the first year this result was separately classified in the programme's records, 638 women (1-5% of all of those assessed) were diagnosed as having borderline cytological changes. The number of women with borderline results has risen steadily, both in absolute numbers and as a proportion of all smears examined. In 1988 and 1989, 4-8% and 4 2% of the women tested had borderline results, and their numbers in both years exceeded 2000, more than the combined total of women with dyskaryotic smears of all grades.
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The Avon Cervical Screening Programme has defined protocols for reporting all categories of abnormal smears and for subsequent patient management. In keeping with these protocols, a great deal of time is spent not only on the initial diagnosis but also on the follow up 
Results
The age specific distribution of borderline test results was highest between 20 and 29 years. After application of the above exclusion criteria, the numbers in the groups aged [20] [21] [22] [23] [24] and 25-29 were 82 and 80 respectively. The duration of follow up of the women with borderline changes ranged from 13 figure 1 with that for the age matched controls. In figure 2 the progression rate in the women with borderlipe results is classified into age groups. The log rank test confirmed a significant difference between the progression of disease in women with borderline results and that in women with normal results (p<0-001). In addition, age significantly affected progression in women with borderline results: those over 40 had a significantly lower rate of progression (p<0-001) than had the women aged between 20 and 39 (fig 2) . In 50% of the women who had developed high grade dyskaryosis within the follow up period, progression had occurred during the first 34 months, but in some the delay was almost eight years, with interim smear test results either classified as normal (roughly a third) or showing low grade dyskaryosis (roughly two thirds). Normal results occurring after the initial borderline change were double screened in the same manner as abnormal smears -that is, by a cytoscreener and a medical laboratory scientific officer-and are therefore considered to be true normal results.
At the time of the initial borderline result 10 women BMJ VOLUME 304 9 MAY 1992 
Discussion
Our results indicate that just over one in every five women (22 4%) presenting with borderline cervical smear cytology in Avon during 1981 subsequently developed high grade dyskaryosis within the nine year follow up period. The risk of progression was greatest in young women (under 39), particularly those in whom the borderline change was not associated with cytological evidence of papillomavirus infection.
Comparison of these findings with those of earlier studies is limited by differences in terminology, in patient selection and treatment, in the duration of follow up, and in the method used to establish the end point diagnosis-histology or cytology.' 35 In a prospective study of 100 women with cervical intraepithelial neoplasia grade I, 39% were found to have human papillomavirus infection by filter DNA hybridisation.'°In 22 of the 26 (85%) who developed progressive disease human papillomavirus type 16 DNA was detected. Mitchell et al calculated that the risk of developing cervical intraepithelial neoplasia grade III was increased 15 6-fold in women with cytological evidence of human papillomavirus infection and 38-7-fold if the women were under 25.14 The risk factor was calculated by comparing the number of carcinomas that developed in women with papillomavirus infection with the expected number of cervical cancers in the general population. The expected incidence figures for the general population were obtained from the South Australian Central Cancer Registry. If women with borderline and those with normal smear test results are analysed together in our study 13 of the 101 (12-9%) women with cytological evidence of human papillomavirus infection progressed to high grade dyskaryosis compared with 88 of the 773 (11-4%) without cytological evidence of viral infection. The risk of progression therefore seems to be increased only slightly, if at all, in women with cytopathic human papillomavirus infection. Our data also show that the cytopathic effects of human papillomavirus infection are almost invariably associated with, or in some cases may be indistinguishable from, borderline cytological changes. This makes it difficult to assess the extent to which cytopathic human papillomavirus infection is an independent risk factor. The present findings suggest that progression from borderline change to high grade dyskaryosis is more likely if cytological evidence of human papillomavirus infection is absent. One possible explanation is that human papillomavirus infection may merely simulate borderline changes without conferring the risk of neoplasia.
Cytological examination alone underestimates the number of women with human papillomavirus infection."5 Nuovo et al showed that neither light microscopy nor clinical examination was of any value in predicting the presence of occult human papillomavirus infection.'6 The women at risk of developing cervical carcinoma may be harbouring latent virus that is not cytologically detectable. In a recent study using the polymerase chain reaction to amplify viral DNA human papillomavirus type 16 DNA was found in 84% of cervical smears that appeared cytologically normal.'7 This unexpectedly high detection rate of human papillomavirus in normal cervices has been confirmed in other studies'8 and serves to emphasise that the evidence linking cervical carcinoma with human papillomaviruses is as yet inconclusive.'9-2
The problem of false negative Papanicolaou smears from invasive cervical carcinomas, as occurred in three patients in the present study, is well recognised."`1 -4 Cervical cytology is thought to be more effective for detecting intraepithelial than invasive carcinoma." In our study all of the women in whom microinvasive carcinoma was found had developed frankly dyskaryotic smears, suggesting that cytological examination may be more reliable in diagnosing microinvasive than deeply invasive carcinoma.
The management of women with borderline smear test results is controversial and entails not only financial and logistical considerations but also a compromise between causing unnecessary anxiety to a large number of women (only some of whom would otherwise develop carcinoma) and failing to detect those women in whom carcinoma could be prevented. Management policies for women with borderline smear cytology vary widely throughout the country. Evans et al recommended that patients with smears showing warty changes, borderline change, or mild dyskaryosis should have a repeat test within three months and be referred for colposcopy if the abnormality persisted. 22 In their discussion of the risk of cervical neoplasia in patients with vulval warts Singer and Jenkins proposed a follow up protocol that, they suggested, would also provide a high level of protection for women with borderline results or human papillomavirus related cervical cytological changes: a repeat smear should be taken at six months and again at 12 months-if both these smears are negative the patients should be discharged to three yearly follow up.2 ' Our results show that borderline change in a cervical smear confers an increased risk, sustained for several years, of progression to high grade dyskaryosis, although in most patients the progression is relatively slow. Our findings suggest that women aged 20 to 39 should be followed up particularly closely, even if one or more subsequent smear test results are negative. We think that a repeat test at three or six months is unlikely to offer much protection against a risk that is clearly a long term one. Every care should be taken to ensure that these women are not lost to follow up and our recommendation would be for annual repeat tests to be submitted for several years before reverting to routine recall.
